Identification of neonates at risk for hazardous hyperbilirubinemia: emerging clinical insights

Pediatr Clin North Am. 2009 Jun;56(3):671-87, Table of Contents. doi: 10.1016/j.pcl.2009.04.005.

Abstract

Hyperbilirubinemia is the most common condition requiring evaluation and treatment in neonates. Identifying among all newborns those few at risk to develop marked hyperbilirubinemia is a clinical challenge. Clinical, epidemiologic, and genetic risk factors associated with severe hyperbilirubinemia include late preterm gestational age, exclusive breastfeeding, glucose-6-phosphate dehydrogenase deficiency, ABO hemolytic disease, East Asian ethnicity, jaundice observed in the first 24 hours of life, cephalohematoma or significant bruising, and history of a previous sibling treated with phototherapy. It is increasingly apparent that the etiopathogenesis of severe hyperbilirubinemia is often multifactorial, and emerging evidence suggests that combining risk factor assessment with measurement of predischarge total serum or transcutaneous bilirubin levels will improve hyperbilirubinemia risk prediction.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Asian Continental Ancestry Group
  • Bilirubin / blood
  • Breast Feeding / adverse effects*
  • Erythroblastosis, Fetal
  • Gestational Age
  • Glucosephosphate Dehydrogenase Deficiency / complications
  • Glucosephosphate Dehydrogenase Deficiency / ethnology
  • Humans
  • Hyperbilirubinemia, Neonatal / epidemiology*
  • Hyperbilirubinemia, Neonatal / etiology
  • Infant, Newborn
  • Infant, Premature
  • Kernicterus / etiology
  • Phototherapy / adverse effects
  • Risk Factors

Substances

  • Bilirubin